Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CRDF - Insiders Buy Cardiff Oncology For Its Cash On Hand Promising Trial Results

CRDF - Insiders Buy Cardiff Oncology For Its Cash On Hand Promising Trial Results

Cardiff Oncology Inc.
  • The Insurgent AI Innovation Model is a holistic machine learning system that has triggered a strong buy alert for Cardiff Oncology, ranking it in the top 6% of its investment universe.
  • Strong clinical readouts have triggered significant price appreciation that has waned in recent months.
  • With $131 million cash on hand, Cardiff is sitting on a war chest that could see them through the next six years.
  • Four insiders have recently disclosed votes of confidence in the company in the form of share purchases. This included two directors, the CEO and COO.

For further details see:

Insiders Buy Cardiff Oncology For Its Cash On Hand, Promising Trial Results
Stock Information
Company Name: Cardiff Oncology Inc.
Stock Symbol: CRDF
Market: NASDAQ
Website: cardiffoncology.com
Menu
CRDF CRDF Quote CRDF Short CRDF News CRDF Articles CRDF Message Board
Get CRDF Alerts

News, Short Squeeze, Breakout and More Instantly...